
Tactiva Therapeutics
- Home
- Companies
- Tactiva Therapeutics
- Products
- Adoptive Cell Therapy
Adoptive Cell Therapy
Adoptive Cell Transfer (ACT) is a form of immunotherapy that targets tumors specifically and potently by utilizing large numbers of a patient’s own immune cells to target and destroy cancer cells. Typically, starting with a few immune cells derived from the patient’s blood, billions of cancer fighting immune cells are manufactured in a special facility, and given back to the patient, almost like a blood transfusion.
Most popular related searches
immune cell
cancer cell destruction
cancer immunotherapy
cancer cell
tumor specificity
immune system
cancer treatment
blood transfusion
cell therapy
immunotherapy
What is Immunotherapy for Cancer Treatment?
Activating the Immune System to Recognize and Fight Cancer
The Advantages of Immunotherapy:
- Power to specifically target cancer
- Possibility for long-term remissions
- Ability to work on many types of cancer – even some that do not respond to chemotherapy or radiation